Price entry $60 - target price $ 66 stop loss $58
Despite the stock been above the average analysts target we remain bullish om the setup technically, there is also the chance of upgrades to follow.
P/E ratio 20.65
Short interest 14.62 % Quite High, but normal in the Pharma sector.
Company profile
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Despite the stock been above the average analysts target we remain bullish om the setup technically, there is also the chance of upgrades to follow.
P/E ratio 20.65
Short interest 14.62 % Quite High, but normal in the Pharma sector.
Company profile
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.